- E-postline.bjorge@uib.no
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2023). TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma. Acta Obstetricia et Gynecologica Scandinavica.
- (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. International Journal of Gynecological Cancer. 1898-1905.
- (2023). Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins. Metabolites. 15 sider.
- (2023). Nemndabort 1979–2022 – hva har skjedd? Tidsskrift for Den norske legeforening.
- (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. Cancer Medicine. 14183-14195.
- (2023). Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study. BJOG: An International Journal of Obstetrics and Gynaecology. 770-778.
- (2023). Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. Cancers. 22 sider.
- (2023). Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis. CMAJ - Canadian Medical Association Journal. E310-E320.
- (2023). Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. The Lancet. 31-43.
- (2022). The WID-EC test for the detection and risk prediction of endometrial cancer. International Journal of Cancer.
- (2022). The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples. Nature Communications.
- (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nature Communications.
- (2022). Symptomatic or asymptomatic recurrence of ovarian cancer: does it influence survival? International Journal of Gynecological Cancer. 1025-1031.
- (2022). Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. Genome Biology.
- (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics. 349-362.
- (2022). Living With Ovarian Cancer: Transitions Lost in Translation. Cancer Care Research Online. 6 sider.
- (2022). Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. Cancers. 20 sider.
- (2022). Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes. Pharmaceuticals.
- (2022). Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction. International Journal of Molecular Sciences.
- (2022). CA-125 levels are predictive of survival in low-grade serous ovarian cancer—A multicenter analysis. Cancers. 1-12.
- (2022). A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets. Journal of Clinical Oncology. 3828-3838.
- (2021). Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods. Cancers. 1-18.
- (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. Communications Medicine. 1-14.
- (2021). Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. Cancer Epidemiology, Biomarkers and Prevention. 1669-1680.
- (2021). Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies . Placenta. 23-31.
- (2021). Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers. Cancer Epidemiology, Biomarkers and Prevention. 217-228.
- (2021). Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model. Molecular Imaging and Biology. 144-155.
- (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. Cancers. 1-18.
- (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. Gynecologic Oncology. 260-267.
- (2020). Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential. Experimental Cell Research. 1-9.
- (2020). DNA methylation signatures to predict the cervicovaginal microbiome status. Clinical Epigenetics.
- (2020). Cholesterol crystals and NLRP3 mediated inflammation in the uterine wall decidua in normal and preeclamptic pregnancies. Frontiers in Immunology. 1-12.
- (2020). CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model . EBioMedicine. 1-12.
- (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. EBioMedicine. 1-13.
- (2019). Shared heritability and functional enrichment across six solid cancers. Nature Communications. 1-23.
- (2019). Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial. The Lancet Oncology. 1409-1419.
- (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 (FMS-like tyrosine kinase receptor 1) biomarker specificity. Hypertension. 1136-1143.
- (2019). Influence of p53 isoform expression on survival in high-grade serous ovarian cancers. Scientific Reports. 1-11.
- (2019). Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. 505-517.
- (2019). Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer. International Journal of Cancer. 1-10.
- (2019). Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American women. Cancer Medicine. 2503-2513.
- (2019). Concentration of fibrin monomer in pregnancy and during the postpartum period. Annals of Clinical Biochemistry. 1-9.
- (2019). Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. The Lancet Oncology. 1171-1182.
- (2019). A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24. Cancer Chemotherapy and Pharmacology. 791-798.
- (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. International Journal of Molecular Sciences. 1-13.
- (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. Clinical Chemistry and Laboratory Medicine. 1-12.
- (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. Annals of Internal Medicine. 326-334.
- (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLOS ONE. 1-13.
- (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. Journal of Magnetic Resonance Imaging. 1637-1647.
- (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiologica. 1010-1017.
- (2018). Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clinical and Experimental Immunology. 84-94.
- (2018). Placental inflammation by HMGB1 activation of TLR4 at the syncytium. Placenta. 53-61.
- (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. BMC Cancer. 1-10.
- (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. BJOG: An International Journal of Obstetrics and Gynaecology. 1695-1703.
- (2018). Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study. British Journal of Cancer. 1123-1129.
- (2018). A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. 5419-5430.
- (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. OncoTarget. 106989-107001.
- (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. OncoTarget. 68530-68541.
- (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. PLOS ONE. 1-12.
- (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. Acta Radiologica. 497-505.
- (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. 680-691.
- (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. British Journal of Cancer. 840-847.
- (2017). C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. PLOS ONE. 1-12.
- (2017). Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. OncoTarget. 64670-64684.
- (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. Acta Obstetricia et Gynecologica Scandinavica. 1162-1169.
- (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. OncoTarget. 69844-69856.
- (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. Nature Genetics. 848-855.
- (2016). The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. Journal of Hypertension. 132-139.
- (2016). The HDACi panobinostat shows growth inhibition both in vitro and in a bioluminescent orthotopic surgical xenograft model of ovarian cancer. PLOS ONE.
- (2016). Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Oncology. 78-89.
- (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS. Journal of Medical Genetics. 800-811.
- (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration. OncoTarget. 72381-72394.
- (2016). Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. International Journal of Epidemiology.
- (2016). Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications.
- (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. Cancer Epidemiology, Biomarkers and Prevention. 61-67.
- (2016). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 1-10.
- (2016). Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study. International Journal of Epidemiology. 1619-1630.
- (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. OncoTarget. 69097-69110.
- (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. 741-756.
- (2016). Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. Obstetrics and Gynecology. 1265-1273.
- (2016). Adult body-mass index and ovarian cancer risk by subtype: A Mendelian randomization study. International Journal of Epidemiology. 884-895.
- (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. Clinical Radiology. 487-494.
- (2015). The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. BMC Pregnancy and Childbirth. 1-12.
- (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. 5955-5964.
- (2015). Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
- (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. International Journal of Gynecological Cancer. 459-466.
- (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers and Prevention. 1574-1584.
- (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. Journal of Nuclear Medicine. 1191-1198.
- (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. Placenta. 1455-1462.
- (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 164-171.
- (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. Nature Genetics. 888-897.
- (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. Gynecologic Oncology. 542-548.
- (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. 689-697.
- (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis. 1341-1353.
- (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. PLOS ONE.
- (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications.
- (2015). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. Cancer Immunology and Immunotherapy. 337-347.
- (2015). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. Cancer Immunology and Immunotherapy. 337-347.
- (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. Acta Obstetricia et Gynecologica Scandinavica. 647-653.
- (2014). Landscape of genomic alterations in cervical carcinomas. Nature. 371-375.
- (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. British Journal of Cancer. 107-114.
- (2014). Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 481-497.
- (2014). First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. PLOS ONE.
- (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 2023-2035.
- (2013). Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 943-950.
- (2013). Validity of pre-eclampsia diagnosis in Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 243-950.
- (2013). Menstrual Cycle and Respiratory Symptoms in a General Nordic-Baltic Population. American Journal of Respiratory and Critical Care Medicine. 366-373.
- (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. European Radiology. 2916-2925.
- (2012). Pregnancy outcomes after paternal radiofrequency field exposure aboard fast patrol boats. Journal of Occupational and Environmental Medicine. 431-438.
- (2012). No effects of MRI scan on male reproduction hormones. Reproductive Toxicology. 133-139.
- (2012). Er det mulig å få pålitelig kunnskap om psykiske senvirkninger etter provosert abort? Tidsskrift for Den norske legeforening. 1450-1452.
- (2011). Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta. 823-829.
- (2011). Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. European Journal of Human Genetics. 796-800.
- (2011). A transcriptional profile of the decidua in preeclampsia. American Journal of Obstetrics and Gynecology. 84, e1-84, e27.
- (2010). STOX2 but not STOX1 is differently expressed in preeclampstic decidua from Norwegian women: data from the Second Nord-Trondelag Health Study. Molecular human reproduction. 960-968.
- (2010). Medical Abortion at 63 to 90 Days of Gestation. Obstetrics and Gynecology. 962-968.
- (2010). Matrix Metalloproteinase 1 in Pre-eclampsia and Fetal Growth Restriction: Reduced Gene Expression in Decidual Tissue and Protein Expression in Extravillous Trophoblasts. Placenta. 615-620.
- (2009). Oral contraception, body mass index, and asthma: A cross-sectional Nordic-Baltic population survey. Journal of Allergy and Clinical Immunology. 391-397.
- (2008). Whole-genome microarray and targeted placental analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PIGF) from pre-eclamptic and small-for-gegstational-age pregnancies. Journal of Maternal-Fetal & Neonatal Medicine. 158-165.
- (2006). Placental expression of glycophosphatidylinositol (GPI)-anchored proteins in paroxysmal nocturnal haemoglobinuria. Scandinavian Journal of Immunology.
- (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. Scandinavian Journal of Immunology. 355-364.
- (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. Scandinavian Journal of Immunology. 355-364.
- (2006). Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. Acta Anaesthesiologica Scandinavica. 324-330.
- (2005). Ascitic complement system in ovarian cancer. British Journal of Cancer. 895-905.
Faglig foredrag
- (2019). The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development. .
- (2017). Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts.
- (2017). An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies.
- (2014). Inflammation in normal and preeclamptic pregnancies.
Vitenskapelig foredrag
- (2023). Decoding the immune and lipid landscape of preeclampsia: A study of disease subtypes and activity.
- (2022). Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids.
- (2022). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds.
- (2021). The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia.
- (2021). The link between inflammatory and vascular pathology and sFlt-1 expression at the maternal-fetal interface in preeclampsia.
- (2021). Systemic immunological perturbations and placental pathology in preeclampsia.
- (2021). Between Illness and Disease: Ovarian Cancer Lost in Translation .
- (2020). Rethinking ovarian cancer: Establishment of an organoid-based preclinical platform for ovarian cancer.
- (2019). What you should know about tumor reductive surgery in advanced ovarian cancer – Clinical recommendations from a patient perspective.
- (2018). Decidual inflammation in normal and preeclamptic pregnancies.
- (2016). Decidual Nrf2-mediated oxidative stress response in preeclampsia and fetal growth restriction.
- (2015). The inflammatory role of HMGB1 in preeclampsia.
- (2013). Preeclampsia and cardiovascular disease - shared causative genetic mechanisms?
- (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
- (2013). A preeclampsia genome-wide linkage scan in Norwegian families.
- (2011). MEDICAL ABORTION WITH HOME ADMINISTRATION OF MISOPROSTOL UP TO 63 DAYS GESTATION.
- (2010). Norway: In transition from surgical to medical termination.
- (2010). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia.
- (2008). Women's choices: Why do they opt for medical abortion?
Leder
- (2023). Advanced endometrial cancer: New medical treatment options on the horizon. Acta Obstetricia et Gynecologica Scandinavica. 128-129.
Populærvitenskapelig artikkel
- (2023). Distinct immunological development throughout pregnancies complicated with preeclampsia, gestational hypertension, and chronic hypertension. Placenta. e15.
Kronikk
- (2023). Skal vi screene og konisere inn i evigheten – eller bytte HPV-vaksine? dagensmedisin.no.
Doktorgradsavhandling
- (2020). Biomarkers and preclinical models for more precise diagnosis and personalized treatment of oral and vulva carcinomas - Study on human samples and experimental models.
- (2019). Rethinking Gynecological High- Grade Serous Carcinoma. Portraying the p53 isoform landscape and development of a new preclinical for optical imaging in xenograft models.
- (1996). Complement regulatory proteins in malignancies. -.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
- (2007). Immunologi og reproduksjon. 6 sider.
Sammendrag/abstract
- (2023). Dyslipidemia and immunological deviation in diagnosed preeclampsia. Placenta. e70-e70.
- (2021). The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia. Pregnancy Hypertension. e20.
- (2021). The link between inflammatory and vascular pathology and sFlt-1 expression at the maternal-fetal interface in preeclampsia. Placenta. e13-e14.
- (2021). Systemic immunological perturbations and placental pathology in preeclampsia. Placenta. e18-e19.
- (2019). Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy . Clinical medicine (London).
- (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. Pregnancy Hypertension. S15.
- (2019). The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development. Placenta. e15.
- (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity. Pregnancy Hypertension. S5.
- (2019). Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction. Pregnancy Hypertension. S21.
- (2018). Decidual inflammation in normal and preeclamptic pregnancies. Pregnancy Hypertension. S33-S34.
- (2017). No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers and Prevention. 420-424.
- (2017). Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Pregnancy Hypertension. 21.
- (2017). An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies. Placenta. 278.
- (2017). An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies. Placenta. 235.
- (2016). NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies. Placenta. 88-88.
- (2015). The inflammatory role of HMGB1 in preeclampsia. Pregnancy Hypertension. 229.
- (2015). Identifying a novel link between preeclampsia and chronic hypertension in the MTHFR gene using the population based Norwegian HUNT Study. Pregnancy Hypertension. 243-244.
- (2015). A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
- (2013). PANOBINOSTAT / CARBOPLATIN DELAY POSTSURGICAL RELAPSE OF OVARIAN CARCINOMA IN AN ORTHOTOPIC MOUSE MODEL. International Journal of Gynecological Cancer. 1 sider.
- (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
- (2013). A preeclampsia genome-wide linkage scan in Norwegian families. Pregnancy Hypertension. 64.
- (2012). Venøs trombose i svangerskapet: Internasjonale retningslinjer blir norske. Gynekologen. 43.
- (2012). Trender i bruken av medikamentell abort i Noreg. Gynekologen.
- (2012). Medical abortion with home administration of misoprostol up to 63 days gestation. Acta Obstetricia et Gynecologica Scandinavica. 33-34.
- (2012). Medical abortion at 9-12 weeks. Acta Obstetricia et Gynecologica Scandinavica. 49-49.
- (2012). INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
- (2012). HPV-vaksinasjon – er kunnskapsnivået hos norske medisinetstudenter og allmennleger tilstrekkelig høyt? Gynekologen. 43.
- (2012). Establishment of a bioluminescence orthotopic mouse model of ovarian carcinoma: Analysis of tumor growth and response to therapy. Acta Obstetricia et Gynecologica Scandinavica. 16-17.
- (2012). A population and family based study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study. Acta Obstetricia et Gynecologica Scandinavica. 135-136.
- (2011). Establishment of a Norwegian Preeclampsia Family Biobank. Placenta. A85-A85.
- (2011). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia and fetal growth restriction. Placenta.
- (2010). Endoplasmatic reticulum stress in decidual tissue from pregnancies complicated with preeclampsia. Hypertension in Pregnancy.
- (2010). Classification of pre-eclamptic pregnancies in health registries. An evaluation of criteria selected and pregnancies included in the Medical Birth Registry of Norway. Hypertension in Pregnancy.
Errata
- (2022). Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362)). European Journal of Human Genetics. 630-631.
- (2022). Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5). Journal of Translational Medicine.
- (2022). Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (Genome Biology, (2022), 23, 1, (52), 10.1186/s13059-022-02603-3). Genome Biology.
- (2019). Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4). Nature Communications.
Vitenskapelig oversiktsartikkel/review
- (2024). Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors. Cancers.
- (2020). The emerging role of cd24 in cancer theranostics—a novel target for fluorescence image-guided surgery in ovarian cancer and beyond. Journal of Personalized Medicine. 1-18.
- (2020). TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies. Journal of Leukocyte Biology. 1-11.
- (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. Nature Reviews Clinical Oncology. 292-309.
- (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 386-401.
- (2012). Respiratory health in women: from menarche to menopause. Expert Review of Respiratory Medicine. 187-202.
Fagartikkel
- (2022). Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. Journal of Translational Medicine. 1-11.
- (2014). Antikoagulasjon ved venøs trombose i svangerskapet. Tidsskrift for Den norske legeforening. 926-926.
Faglig kapittel
- (2021). Xenograft Models of Ovarian Cancer for Therapy Evaluation. . I:
- (2021). Ovarian Cancer Methods and Protocols. Springer Nature.